8-KItem 5.02 · Officer/Director ChangeItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements
Elevance Health ($ELV) reaffirms FY2026 EPS guidance: ≥ $22.30 diluted (includes ~ $3.20 of net…
Filed with the SEC on · Summarized by InvestorsBot
Elevance Health ($ELV) reaffirms FY2026 EPS guidance: ≥ $22.30 diluted (includes ~ $3.20 of net unfavorable items); adjusted EPS excluding those items ≥ $25.50. 📈🏥 #Earnings #Guidance
Reg FD disclosure: Elevance ($ELV) reaffirms FY2026 benefit expense ratio guidance at 90.2% ±50 bps. Filed 2026-02-26 under Item 7.01. 🔁📊 #Healthcare #Profitability
Elevance ($ELV) notes Item 7.01 info is furnished (not "filed" under Section 18) and contains forward-looking statements subject to risks—see SEC filings for details. ⚠️📃 #SEC #Risk